Search research articles
Contact Us
Filters
Showing results (111-120 of 129) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
September 1, 2001
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study
E Vellenga, M van Agthoven, A J Croockewit, et al.
Bone Marrow Transplantation
|
April 1, 1999
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma
H M Lokhorst, P Sonneveld, J J Cornelissen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group
A W Dekker, M B van't Veer, W Sizoo, et al.
Leukemia
|
May 25, 2011
Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia
T Lodewyck, M Oudshoorn, B van der Holt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 1998
Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation
Y Belkacemi, M Labopin, J P Vernant, et al.
Blood
|
August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT
J W van Esser, B van der Holt, E Meijer, et al.
British Journal of Haematology
|
June 19, 2001
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation
J W van Esser, H G Niesters, S F Thijsen, et al.
Annals of Hematology
|
October 13, 2006
High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study
W Deenik, B van der Holt, G E G Verhoef, et al.
Bone Marrow Transplantation
|
February 8, 2005
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants
G Gahrton, S Iacobelli, J Apperley, et al.
Blood
|
December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation
B B Björkstrand, P Ljungman, H Svensson, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 129) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
September 1, 2001
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study
E Vellenga, M van Agthoven, A J Croockewit, et al.
Bone Marrow Transplantation
|
April 1, 1999
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma
H M Lokhorst, P Sonneveld, J J Cornelissen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group
A W Dekker, M B van't Veer, W Sizoo, et al.
Leukemia
|
May 25, 2011
Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia
T Lodewyck, M Oudshoorn, B van der Holt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 1998
Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation
Y Belkacemi, M Labopin, J P Vernant, et al.
Blood
|
August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT
J W van Esser, B van der Holt, E Meijer, et al.
British Journal of Haematology
|
June 19, 2001
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation
J W van Esser, H G Niesters, S F Thijsen, et al.
Annals of Hematology
|
October 13, 2006
High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study
W Deenik, B van der Holt, G E G Verhoef, et al.
Bone Marrow Transplantation
|
February 8, 2005
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants
G Gahrton, S Iacobelli, J Apperley, et al.
Blood
|
December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation
B B Björkstrand, P Ljungman, H Svensson, et al.
Page
of 13